| GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers (NCT01978327) | GlaxoSmithKline | 2013-11-22 |
| A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects (NCT01992380) | Avid Radiopharmaceuticals | 2013-11-13 |
| Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (NCT01953601) | Merck Sharp & Dohme LLC | 2013-11-05 |
| Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment (NCT02291783) | Nxera Pharma UK Limited | 2013-11-01 |
| Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men (NCT02010476) | University of Eastern Finland | 2013-11-01 |
| Study of Degenerescence CSF Hallmarks in Older Bipolar Patients (NCT02836054) | University Hospital, Grenoble | 2013-11-01 |
| Riluzole in Mild Alzheimer's Disease (NCT01703117) | Icahn School of Medicine at Mount Sinai | 2013-11-01 |
| A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease (NCT01966666) | University of California, San Francisco | 2013-11-01 |
| Alzheimer's Prevention Through Exercise (NCT02000583) | University of Kansas Medical Center | 2013-11-01 |
| Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation (NCT02005380) | German-Jordanian University | 2013-11-01 |
| Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) (NCT01852110) | Merck Sharp & Dohme LLC | 2013-10-22 |
| Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease (NCT01969136) | FORUM Pharmaceuticals Inc | 2013-10-01 |
| Effect of NeuroAD on the Cognitive Function of Alzheimer Patients (NCT01825330) | Neuronix Ltd | 2013-10-01 |
| Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil (NCT01955161) | H. Lundbeck A/S | 2013-10-01 |
| Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease (NCT01969123) | FORUM Pharmaceuticals Inc | 2013-10-01 |
| Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)) (NCT01993628) | University Hospital, Strasbourg, France | 2013-10-01 |
| Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation (NCT01958437) | VA Office of Research and Development | 2013-10-01 |
| 10-Year Survival After Acute Hip Fracture in Patients With Preclinical/Clinical Alzheimer Pathology (NCT07443566) | Bengt Nellgård | 2013-10-01 |
| Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease (NCT01636596) | Louisiana State University Health Sciences Center Shreveport | 2013-09-01 |
| Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type (NCT01922258) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-09-01 |
| Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD (NCT01920672) | Johns Hopkins University | 2013-09-01 |
| Zydena on Cognitive Function of Alzheimer's Disease Patients (NCT01940952) | Samsung Medical Center | 2013-09-01 |
| Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints. (NCT02309723) | Tufts Medical Center | 2013-09-01 |
| African American Alzheimer's Progression Markers - CSF and Neuro-Imaging (NCT02089555) | Emory University | 2013-09-01 |
| A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease (NCT02094729) | Eisai Co., Ltd. | 2013-09-01 |
| PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers (NCT01826110) | Johns Hopkins University | 2013-09-01 |
| A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. (NCT01924858) | GlaxoSmithKline | 2013-08-19 |
| Benefits of Exercise in Alzheimer's Disease (NCT01935024) | University Health Network, Toronto | 2013-08-01 |
| Sleep, Aging and Risk for Alzheimer's Disease (NCT01962779) | NYU Langone Health | 2013-07-31 |
| tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia (NCT02873546) | Centre Hospitalier Universitaire de Besancon | 2013-07-19 |
| A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation (NCT01862640) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-07-11 |
| Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease (NCT01841905) | Rhode Island Hospital | 2013-07-01 |
| Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease (NCT01864655) | Stephen M. Strittmatter | 2013-07-01 |
| Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors (NCT01908010) | AbbVie | 2013-07-01 |
| Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo (NCT01900665) | Eli Lilly and Company | 2013-07-01 |
| Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease (NCT01885806) | Federal University of Minas Gerais | 2013-06-01 |
| Human Brain Antioxidants During Oxidative Stress (NCT01713816) | University of Minnesota | 2013-06-01 |
| Down Syndrome Biomarker Initiative (DSBI) (NCT02141971) | Michael Rafii | 2013-06-01 |
| Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006 (NCT02008513) | Affiris AG | 2013-06-01 |
| Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice (NCT02162264) | Eisai Co., Ltd. | 2013-06-01 |
| The Effect of rTMS Treatment on Alzheimer's and Sleep Quality (NCT01894620) | Dr. Zahra Kazem-Moussavi | 2013-05-01 |
| Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project (NCT01798199) | Centre Hospitalier Universitaire de Nice | 2013-05-01 |
| A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease (NCT02017340) | Prof Brian Lawlor | 2013-04-24 |
| Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs. (NCT01859767) | Molecular NeuroImaging | 2013-04-01 |
| Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease (NCT01847586) | Centre for Addiction and Mental Health | 2013-04-01 |
| AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NCT01741194) | Cerecin | 2013-03-01 |
| Effect of NeuroAD on Alzheimer Patients (NCT01825317) | Neuronix Ltd | 2013-03-01 |
| Bexarotene Amyloid Treatment for Alzheimer's Disease (NCT01782742) | The Cleveland Clinic | 2013-02-01 |
| Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease (NCT01849042) | Konkuk University Medical Center | 2013-01-01 |
| The Detection of Early Dementia With the Digital Game Memory (NCT02041728) | Universitaire Ziekenhuizen KU Leuven | 2013-01-01 |
| Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration (NCT02964611) | University Health Network, Toronto | 2013-01-01 |
| Volunteers Adding Life in Dementia: VALID (NCT01715181) | Queen's University | 2013-01-01 |
| Effect of Insulin Sensitizer Metformin on AD Biomarkers (NCT01965756) | University of Pennsylvania | 2013-01-01 |
| A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease (NCT01766336) | OPKO Health, Inc. | 2013-01-01 |
| Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (NCT01689246) | TauRx Therapeutics Ltd | 2013-01-01 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease (NCT01767311) | Eisai Inc. | 2012-12-20 |
| A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab (NCT01723826) | Genentech, Inc. | 2012-12-07 |
| Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment (NCT01723670) | CERESPIR | 2012-12-01 |
| The Role of Mid-Life Adiposity in Functional Brain Connectivity (NCT01777789) | Medical College of Wisconsin | 2012-12-01 |
| Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements (NCT01745198) | Pamlab, Inc. | 2012-12-01 |
| An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) (NCT01739348) | Merck Sharp & Dohme LLC | 2012-11-30 |
| Long-Term Study of IGIV, 10% in Alzheimer´s Disease (NCT01736579) | Baxalta now part of Shire | 2012-11-29 |
| Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects (NCT01702480) | GlaxoSmithKline | 2012-11-05 |
| Clinical Pathway for Alzheimer's Disease in China (CPAD) (NCT01779310) | Peking University | 2012-11-01 |
| Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) (NCT01708304) | University of Washington | 2012-11-01 |
| Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease (NCT01735630) | OPKO Health, Inc. | 2012-11-01 |
| Safety and Efficacy of MT-4666 (NCT01764243) | Tanabe Pharma Corporation | 2012-11-01 |
| Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease (NCT01661673) | FORUM Pharmaceuticals Inc | 2012-11-01 |
| Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil (NCT01712074) | Pfizer | 2012-11-01 |
| Korea Alzheimer's Disease Neuroimaging Initiative (NCT01979419) | Korean Alzheimers' Disease Neuroimaing Intitiative | 2012-11-01 |
| A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy (NCT01677754) | Hoffmann-La Roche | 2012-10-24 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers (NCT01702467) | GlaxoSmithKline | 2012-10-19 |
| Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease (NCT01677572) | Biogen | 2012-10-05 |
| A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) (NCT01662882) | Avid Radiopharmaceuticals | 2012-10-01 |
| Indiana University Dementia Screening Trial (NCT01699503) | Indiana University | 2012-10-01 |
| An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption (NCT01716897) | Eisai Inc. | 2012-10-01 |
| Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline (NCT01703702) | Avid Radiopharmaceuticals | 2012-10-01 |
| Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease (NCT01689233) | TauRx Therapeutics Ltd | 2012-10-01 |
| Comparison of PET Amyloid Imaging in Japanese and Western Subjects (NCT02813070) | GE Healthcare | 2012-10-01 |
| Alzheimer Disease : Rehabilitation's Intervention at Home (NCT01689948) | Nantes University Hospital | 2012-10-01 |
| Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (NCT01626391) | TauRx Therapeutics Ltd | 2012-09-01 |
| Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease (NCT01584440) | Avanir Pharmaceuticals | 2012-08-13 |
| A Study of Florbetapir (18F) in Japanese Healthy Volunteers (NCT01660815) | Avid Radiopharmaceuticals | 2012-08-01 |
| Arterial Spin Labeling (ASL) MRI for Cognitive Decline (NCT01727622) | University of Pennsylvania | 2012-08-01 |
| This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease (NCT01676935) | AbbVie (prior sponsor, Abbott) | 2012-08-01 |
| Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02) (NCT01600859) | Eisai Inc. | 2012-07-01 |
| Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images (NCT01672827) | GE Healthcare | 2012-07-01 |
| Effects of Light-therapy in Alzheimer's Disease (NCT02686190) | Assistance Publique - Hôpitaux de Paris | 2012-07-01 |
| Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias (NCT01730430) | Duke University | 2012-07-01 |
| Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) (NCT01614886) | Novartis Pharmaceuticals | 2012-07-01 |
| Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET) (NCT01607476) | Mayo Clinic | 2012-07-01 |
| Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults (NCT01609335) | Mayo Clinic | 2012-07-01 |
| Use of Saliva for Alzheimer's Disease Diagnosis (NCT02864303) | University Hospital, Montpellier | 2012-06-21 |
| A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients (NCT01656525) | Chugai Pharmaceutical | 2012-06-01 |
| Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase (NCT01602393) | Chiesi Farmaceutici S.p.A. | 2012-05-01 |
| Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's (NCT02502045) | Yale University | 2012-05-01 |
| Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease? (NCT01695889) | University Hospital, Linkoeping | 2012-05-01 |
| Multi-modal Neuroimaging in Alzheimer's Disease IMAP+ (NCT01638949) | University Hospital, Caen | 2012-05-01 |
| Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease (NCT01715350) | VTBIO Co. LTD | 2012-05-01 |
| Mirtazapine for Sleep Disorders in Alzheimer's Disease (NCT01867775) | Brasilia University Hospital | 2012-05-01 |